Provided by Tiger Fintech (Singapore) Pte. Ltd.

Reviva Pharmaceuticals Holdings, Inc.

0.5997
-0.0046-0.76%
Post-market: 0.60000.0003+0.05%19:57 EDT
Volume:3.77M
Turnover:2.26M
Market Cap:57.77M
PE:-0.94
High:0.6160
Open:0.6100
Low:0.5851
Close:0.6043
52wk High:4.28
52wk Low:0.2522
Shares:96.34M
Float Shares:89.25M
Volume Ratio:0.30
T/O Rate:4.22%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6355
EPS(LYR):-0.9026
ROE:-916.17%
ROA:-173.70%
PB:-125.83
PE(LYR):-0.66

Loading ...

Reviva Pharm Holdings Is Maintained at Speculative Buy by Benchmark

Dow Jones
·
Sep 15

Reviva Pharmaceuticals Holdings Inc : Benchmark Cuts Target Price to $7 From $14

THOMSON REUTERS
·
Sep 15

Reviva Pharm Holdings Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Aug 18

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Aug 18

Reviva Pharm Holdings Is Maintained at Buy by Maxim Group

Dow Jones
·
Aug 16

Reviva Pharmaceuticals Holdings Inc reports results for the quarter ended June 30 - Earnings Summary

Reuters
·
Aug 15

Reviva Pharmaceuticals Q2 EPS $(0.12) Beats $(0.13) Estimate

Benzinga
·
Aug 15

BRIEF-Reviva Pharmaceuticals Q2 EPS USD -0.12

Reuters
·
Aug 15

Reviva Reports Second Quarter 2025 Financial Results and Recent Business Highlights

GlobeNewswire
·
Aug 15

Reviva Pharmaceuticals Holdings Inc expected to post a loss of 11 cents a share - Earnings Preview

Reuters
·
Aug 09

Reviva Pharm Holdings Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Jun 27

Reviva Pharmaceuticals Prices $10 Million Public Offering

MT Newswires Live
·
Jun 26

Reviva Pharmaceuticals Appoints Baker Tilly as New Auditor Following Moss Adams Merger

Reuters
·
Jun 07

Reviva Pharm Holdings Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Jun 03

BRIEF-Reviva Announces Positive Full Dataset For 1-Year Phase 3 Recover Open Label Extension Study Evaluating Brilaroxazine In Schizophrenia

Reuters
·
Jun 02

BRIEF-Reviva Pharmaceuticals Holdings Inc - Enters Into At Market Issuance Sales Agreement - SEC Filing

Reuters
·
May 31

Reviva Pharmaceuticals Launches $50 Million At-The-Market Stock Offering Through B. Riley Securities and Alliance Global Partners

Reuters
·
May 31

Reviva Pharm Holdings Is Maintained at Buy by D. Boral Capital

Dow Jones
·
May 20

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 16

Reviva Pharmaceuticals Holdings Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 16